[Federal Register Volume 83, Number 27 (Thursday, February 8, 2018)]
[Notices]
[Page 5635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02492]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; R13 Conference Grants Review.
    Date: March 6, 2018.
    Time: 1:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, Room 
1037, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Rahat Khan, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Democracy Blvd., Rm. 1078, Bethesda, MD 
20892, 301-594-7319, [email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; TRND--Contract Review.
    Date: March 7, 2018.
    Time: 1:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, One Democracy Plaza, Room 
1037, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Democracy Blvd., Rm. 1078, Bethesda, MD 
20892, 301-894-7319, [email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; Platform Delivery Technologies for 
Nucleic Acid Therapeutics.
    Date: March 29, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, Room 
1065, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Carol Lambert, Ph.D., Acting Director, Office of 
Scientific Review, National Center for Advancing Translational 
Sciences (NCATS), National Institutes of Health, 6701 Democracy 
Blvd., Democracy 1, Room 1076, Bethesda, MD 20892, 301-435-0814, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: February 1, 2018.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02492 Filed 2-7-18; 8:45 am]
BILLING CODE 4140-01-P